Seikagaku announces the conclusion of a Letter of Intent for an Overseas Exclusive License Agreement for SI-6603, a Novel Treatment for Lumbar Disc Herniation
Seikagaku announces the conclusion of a Letter of Intent for an Overseas Exclusive License Agreement for SI-6603, a Novel Treatment for Lumbar Disc Herniation
06.15.2016
This link will direct you to a third-party site.(Another window opens.)
The Seikagaku Corporation website uses cookies to personalize contents and offer a better browsing experience. Please click the Accept botton. (Read more)